ArticleScientific reports2025
Clinical-imaging diversity of exudative pulmonary cryptococcosis with different immune states.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Based on a radiomics-clinical nomogram to predict the therapeutic effect of pulmonary cryptococcosis pneumonia.Scientific reports · 2026Article
- Pulmonary cryptococcosis beyond human immunodeficiency virus: a five-year cohort study of diagnostic challenges, radiologic mimics, and clinical predictors.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to evaluate the clinical-imaging diversity of exudative pulmonary cryptococcosis (PC) with different immune states. The clinical and imaging data of 76 patients with PC (immunocompetent exudative PC 36 cases and immunocompromised exudative PC 40 cases) were respectively reviewed to determine the diagnostic features. Immunocompromised exudative PC was more often with bilateral distribution (30.6% vs. 80.0%, P < 0.001), ground-glass reticular pattern (13.9% vs. 52.5%, P < 0.001), mediastinal lymphadenopathy (0 vs. 20.0%, P = 0.014) and pleural effusion (0 vs. 22.5%, P = 0.007). The inflammatory response (66.7% vs. 20.0%, P < 0.001) and perifissural consolidation (52.8% vs. 12.5%, P < 0.001) were more common in immunocompetent exudative PC. The exudative PC had diverse clinical and imaging findings under different immune states. Inflammatory response, perifissural consolidation, bilateral distribution, ground-glass reticular pattern, mediastinal lymphadenopathy, and pleural effusion could suggest exudative PC with different immune states and provide reliable evidence for clinical diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.